Gelesis Holdings, Inc.
(NYSE : GLS)

( )
GLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.01%540.151.0%$846.77m
ABMDABIOMED, Inc. -0.23%377.233.3%$782.17m
DHRDanaher Corp. -2.20%261.170.7%$680.05m
MDTMedtronic Plc -3.72%76.180.6%$623.48m
ISRGIntuitive Surgical, Inc. -0.94%262.640.8%$530.00m
ABTAbbott Laboratories -1.44%105.420.8%$507.99m
EWEdwards Lifesciences Corp. -0.76%75.780.4%$447.08m
BDXBecton, Dickinson & Co. -0.26%237.441.0%$445.88m
SYKStryker Corp. -2.30%227.391.3%$376.10m
DXCMDexCom, Inc. 0.51%112.571.9%$295.16m
BSXBoston Scientific Corp. -0.73%43.831.0%$262.65m
BAXBaxter International, Inc. -1.46%55.191.8%$241.09m
AAgilent Technologies, Inc. -2.96%152.311.7%$214.21m
ALGNAlign Technology, Inc. -2.51%189.786.4%$211.90m
WSTWest Pharmaceutical Services, Inc. -1.05%224.281.6%$197.87m

Company Profile

Gelesis Holdings, Inc. operates as a biotechnology company. The firm engages in developing novel category of therapies for weight management and gut related chronic diseases. The company was founded on February 15, 2006 by Yishai Zohar and is headquartered in Boston, MA.